Meenu Chhabra - 23 Feb 2022 Form 3 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Issuer symbol
GRI
Transactions as of
23 Feb 2022
Net transactions value
$0
Form type
3
Filing time
09 Mar 2022, 16:01:46 UTC
Next filing
08 Aug 2022

No securities are beneficially owned.

Remarks:

Reported late due to administrative error. Exhibit 24 - Power of Attorney